Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:3378

Official publication of the Indian Society of Nephrology
 ~   Next article
 ~   Previous article
 ~   Table of Contents

 ~   Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~   Citation Manager
 ~   Access Statistics
 ~   Reader Comments
 ~   Email Alert *
 ~   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3464    
    Printed127    
    Emailed2    
    PDF Downloaded160    
    Comments [Add]    
    Cited by others 5    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2010  |  Volume : 20  |  Issue : 3  |  Page : 142-145

Sildenafil citrate can improve erectile dysfunction among chronic hemodialysis patients


Department of Internal Medicine, Urmia University of Medical Sciences, Imam Khomeini Training Hospital, Urmia, Iran

Correspondence Address:
N Sepehrvand
Students' Research Committee, Deputy for Research Affairs, Urmia University of Medical Sciences, Resalat Avenue, Djahad Square, Urmia
Iran
Login to access the Email id

Source of Support: Urmia University of Medical Sciences (UMSU), Conflict of Interest: None


DOI: 10.4103/0971-4065.70845

Rights and Permissions

Erectile dysfunction (ED) is common among patients with end-stage renal disease (ESRD), who undergo hemodialysis (HD). The aim of this study was to evaluate the safety and effectiveness of sildenafil in male HD patients with ED. Twenty-seven HD patients were recruited for this prospective, randomized, double-blind, placebo-controlled, clinical trial study of sildenafil during a period of 1 week. Efficacy was assessed by using the International Index of Erectile Function (IIEF) before and 1 week after treatment. Baseline demographic and clinical features were similar in both the groups. There was a weak correlation between ED and duration of undergoing dialysis (P = 0.073). There was significant relationship between sildenafil usage and improvement in erectile function (P < 0.0001). Placebo improved significantly the erectile function (P = 0.016), perhaps by psychological way. However, sildenafil had a more significant effect than placebo in increasing IIEF score among HD patients (P = 0.00 compared to 0.016). Sildenafil is effective and safe for treating ED among HD patients.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07